John Celebi serves as Executive at Sensei Biotherapeutics, Inc., where they oversee executive responsibilities. Since joining the company, John Celebi has executed 8 insider transactions totaling $425, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 15, 2024 involved selling 5,891 shares valued at $4.7K.
John Celebi currently holds 105,420 shares of Sensei Biotherapeutics, Inc. (SNSE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Celebi has been a net buyer of SNSE stock. They have purchased $425 and sold $0 worth of shares.
John Celebi's most recent insider trade was on Feb 15, 2024, when they sold 5,891 shares at $0.79 per share.
Get notified when new Form 4 filings are submitted
| $0.85 |
| Discretionary |
| Feb 15, 2023 | SNSE | $30.7K | Payment | 20,492 | $1.50 | Discretionary |
| Feb 15, 2023 | SNSE | $0 | Award | 51,893 | $N/A | Discretionary |
| Feb 15, 2023 | SNSE | $0 | Award | 21,300 | $N/A | Discretionary |
| Feb 15, 2023 | SNSE | $0 | Award | 51,893 | $N/A | Discretionary |
| Feb 15, 2023 | SNSE | $0 | Award | 21,300 | $N/A | Discretionary |
| Feb 15, 2022 | SNSE | $0 | Award | 53,900 | $N/A | Discretionary |